CBD Industry Company Overview – No Evident Investigative Leads
CBD Industry Company Overview – No Evident Investigative Leads The passage is a routine market analysis of publicly traded CBD companies, containing only financial metrics, product descriptions, and investment plans. It mentions no high‑profile individuals, government agencies, or alleged wrongdoing, offering no actionable investigative leads. Key insights: 1933 Industries reports $12.6 M revenue in 2018 with 49% gross margin.; Canopy Growth received a $4 bn investment from Constellation Brands and plans up to $500 M for U.S. CBD infrastructure.; Charlotte’s Web generated $48 M revenue in FY 9M18 with a 77% gross margin and plans international expansion.
Summary
CBD Industry Company Overview – No Evident Investigative Leads The passage is a routine market analysis of publicly traded CBD companies, containing only financial metrics, product descriptions, and investment plans. It mentions no high‑profile individuals, government agencies, or alleged wrongdoing, offering no actionable investigative leads. Key insights: 1933 Industries reports $12.6 M revenue in 2018 with 49% gross margin.; Canopy Growth received a $4 bn investment from Constellation Brands and plans up to $500 M for U.S. CBD infrastructure.; Charlotte’s Web generated $48 M revenue in FY 9M18 with a 77% gross margin and plans international expansion.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.